Prothena
focuses on the development of novel protein immunotherapies for the treatment of cell adhesion... Read moreProthena
focuses on the development of novel protein immunotherapies for the treatment of cell adhesion... Read more
News
Feb 28, 2025
Owler
Prothena Corporation plc: Prothena's employee count changed from 173 in Dec 2023 to 163 in Dec 2024
Feb 21, 2025
Seeking Alpha
Prothena: Prothena outlines potential multi-billion dollar opportunity with birtamimab launch by 2026
Feb 21, 2025
Seeking Alpha
Prothena: Prothena Corporation plc 2024 Q4 - Results - Earnings Call Presentation
Feb 17, 2025
GlobalNewswire
Press Release: Prothena : Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm
Feb 01, 2025
Americanbankingnews
Prothena: Zacks Research Has Positive Outlook for Prothena Q2 Earnings
Dec 22, 2024
Seeking Alpha
Prothena: Prothena Surges After Parkinson's Drug Misses Primary Endpoint
Dec 19, 2024
BioPharma-Reporter
Prothena: Roche and Prothena's Parkinson's antibody treatment fails at phase 2
Nov 13, 2024
Owler
Prothena Corporation plc: Prothena's revenue changed from $217.25M in Jun 2024 to $133.35M in Sep 2024
Nov 13, 2024
Zacks
Prothena: Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus
Oct 18, 2024
Seeking Alpha
Prothena: Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)
Prothena Competitors
1
2
3
4
5
6
7
8
9
10